ArticleEMBO reports2015
Ethics and germline gene editing.
Article in EMBO reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The ethics of clinical applications of germline genome modification: a systematic review of reasons.Human reproduction (Oxford, England) · 2018Pooled it
- Gene Editing for Enhanced Swine Production: Current Advances and Prospects.Animals : an open access journal from MDPI · 2025Review
- Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies.Stem cell research & therapy · 2025Review
- CRISPR-Based Gene Editing: a Modern Approach for Study and Treatment of Cancer.Applied biochemistry and biotechnology · 2024Review
- Eight Strategies to Engineer Acceptance of Human Germline Modifications.Journal of bioethical inquiry · 2024Article
- Responsible governance of human germline genome editing in China†.Biology of reproduction · 2022Article
- Elucidation of CRISPR-Cas9 application in novel cellular immunotherapy.Molecular biology reports · 2022Article
- A review of COVID-19: Treatment strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease.Saudi journal of biological sciences · 2022Review
- CRISPR in the North American popular press.Genetics in medicine : official journal of the American College of Medical Genetics · 2019Article
- Women who suffer from schizophrenia: Critical issues.World journal of psychiatry · 2018Review
- Trust in Science: CRISPR-Cas9 and the Ban on Human Germline Editing.Science and engineering ethics · 2018Article
- Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE.European journal of human genetics : EJHG · 2018Article
- Responsible innovation in human germline gene editing. Background document to the recommendations of ESHG and ESHRE.Human reproduction open · 2018Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.